Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Prepaid Assets (2022 - 2025)

Zentalis Pharmaceuticals has reported Prepaid Assets over the past 4 years, most recently at $11.4 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $11.4 million for Q4 2025, up 14.27% from a year ago — trailing twelve months through Dec 2025 was $11.4 million (up 14.27% YoY), and the annual figure for FY2025 was $11.4 million, up 14.27%.
  • Prepaid Assets for Q4 2025 was $11.4 million at Zentalis Pharmaceuticals, up from $7.6 million in the prior quarter.
  • Over the last five years, Prepaid Assets for ZNTL hit a ceiling of $27.2 million in Q1 2023 and a floor of $7.6 million in Q3 2025.
  • Median Prepaid Assets over the past 4 years was $16.7 million (2023), compared with a mean of $16.8 million.
  • Biggest five-year swings in Prepaid Assets: increased 25.8% in 2024 and later tumbled 59.31% in 2025.
  • Zentalis Pharmaceuticals' Prepaid Assets stood at $24.3 million in 2022, then plummeted by 43.18% to $13.8 million in 2023, then dropped by 27.66% to $10.0 million in 2024, then increased by 14.27% to $11.4 million in 2025.
  • The last three reported values for Prepaid Assets were $11.4 million (Q4 2025), $7.6 million (Q3 2025), and $8.2 million (Q2 2025) per Business Quant data.